Sort
82,697 grants matching “vaccine development”
Macaque T cell signatures of Mtb control
$688,445Jyothi Rengarajan · Emory University · U19 · FY2016 · AI
Engineered âmuco-trappingâ antibodies for inhaled therapy of parainfluenza and human metapneumovirus infections
$688,413Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
Animal Core
$688,409Saverio Vincent Capuano · University Of Miami School Of Medicine · P01 · FY2016 · AI
Mechanism and Inhibition of Thogotovirus Entry
$688,397Adrianus Cm Boon · Washington University · R01 · FY2024 · AI
Developmental Projects
$688,393Dennis L. Kasper · Harvard Medical School · U54 · FY2010 · AI
Epitope-Based CSP Vaccines Optimized to Achieve Long-Term Sterile Immunity
$688,369David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2023 · AI
Epitope-Based CSP Vaccines Optimized to Achieve Long-Term Sterile Immunity
$688,369David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2024 · AI
Epitope-Based CSP Vaccines Optimized to Achieve Long-Term Sterile Immunity
$688,369David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2025 · AI
Gene Transfer and Somatic Cell Engineering Core
$688,332Isabelle Riviere · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Engineered âmuco-trappingâ antibodies for inhaled therapy of parainfluenza and human metapneumovirus infections
$688,330Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
Columbia University-Southern African AIDS International Training/Research Program
$688,329Quarraisha Abdool Karim · Columbia University Health Sciences · D43 · FY2013 · TW
Effect of host immunity stimulated by viral IL-10-deleted RhCMV vaccines on SIV rebound
$688,290Dennis J Hartigan-O'Connor · University Of California At Davis · P01 · FY2019 · AI
An immunodominance-based Pan-Pneumovirus vaccine for protection against RSV and hMPV
$688,268Jarrod Mousa · Florida State University · R01 · FY2025 · AI
Prospective study of cutaneous viral infections and non-melanoma skin cancer
$688,262Dana Elise Rollison · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · CA
Center for Humanized Mice
$688,191Larisa Y Poluektova · University Of Nebraska Medical Center · R24 · FY2014 · OD
Understanding the rectal mucosal effects of cross-sex hormone therapy among US and Thai transgender women
$688,177Colleen F Kelley · Emory University · R01 · FY2021 · AI
Vector-Borne Diseases: Molecular Mechanisms in Vector-Host Interactions
$688,176Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Multi-Omics Characterization of Plasmodium Vivax Hypnozoites
$688,160David Serre · University Of Maryland Baltimore · R01 · FY2025 · AI
NYC Transit Workers and COVID-19: Impact of Multilevel Interventions
$688,149Robyn R.m. Gershon · New York University · R01 · FY2024 · NR
Non-Human Primate Core
$688,141Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIC · FY2012 · AI
Non-Human Primate Core
$688,141Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIC · FY2013 · AI
NK cell-mediated regulation of T cell immunity in TB/HIV co-infection
$688,115Cheryl Liane Day · Emory University · R01 · FY2018 · AI
mRNA-encoded Cas13 as a pan-respiratory antiviral
$688,094Philip J Santangelo · Emory University · R01 · FY2025 · AI
Transfer of vaccine-induced immunity from immunocompetent stem cell donor as antiviral immunotherapy to protect high-risk transplant recipients from cytomegalovirus reactivation
$688,080Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
CIVIC SARS-CoV-2 Research Activities
$688,076Tony Moody · Duke University · N01 · FY2022 · AI